Liepinsh E - Search Results

1

Cardiac metabolism as a driver and therapeutic target of myocardial infarction.

Zuurbier CJ, Bertrand L, Beauloye CR, Andreadou I, Ruiz-Meana M, Jespersen NR, Kula-Alwar D, Prag HA, Eric Botker H, Dambrova M, Montessuit C, Kaambre T, Liepinsh E, Brookes PS, Krieg T. Zuurbier CJ, et al. Among authors: liepinsh e. J Cell Mol Med. 2020 Jun;24(11):5937-5954. doi: 10.1111/jcmm.15180. Epub 2020 May 8. J Cell Mol Med. 2020. PMID: 32384583 Free PMC article. Review.

2

Mildronate: cardioprotective action through carnitine-lowering effect.

Dambrova M, Liepinsh E, Kalvinsh I. Dambrova M, et al. Among authors: liepinsh e. Trends Cardiovasc Med. 2002 Aug;12(6):275-9. doi: 10.1016/s1050-1738(02)00175-5. Trends Cardiovasc Med. 2002. PMID: 12242052 Review.

3

Investigations on the pharmacology of the cardioprotective guanidine ME10092.

Dambrova M, Liepinsh E, Kirjanova O, Petrovska R, Pugovich O, Baumane L, Uhlen S, Kalvinsh I, Oliver D, Wikberg JE. Dambrova M, et al. Among authors: liepinsh e. J Cardiovasc Pharmacol. 2004 Aug;44(2):178-86. doi: 10.1097/00005344-200408000-00006. J Cardiovasc Pharmacol. 2004. PMID: 15243298

4

Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction.

Liepinsh E, Vilskersts R, Loca D, Kirjanova O, Pugovichs O, Kalvinsh I, Dambrova M. Liepinsh E, et al. J Cardiovasc Pharmacol. 2006 Dec;48(6):314-9. doi: 10.1097/01.fjc.0000250077.07702.23. J Cardiovasc Pharmacol. 2006. PMID: 17204911

5

Functional evaluation of THIQ, a melanocortin 4 receptor agonist, in models of food intake and inflammation.

Muceniece R, Zvejniece L, Vilskersts R, Liepinsh E, Baumane L, Kalvinsh I, Wikberg JE, Dambrova M. Muceniece R, et al. Among authors: liepinsh e. Basic Clin Pharmacol Toxicol. 2007 Dec;101(6):416-20. doi: 10.1111/j.1742-7843.2007.00133.x. Basic Clin Pharmacol Toxicol. 2007. PMID: 18028105 Free article.

6

Comparative pharmacological activity of optical isomers of phenibut.

Dambrova M, Zvejniece L, Liepinsh E, Cirule H, Zharkova O, Veinberg G, Kalvinsh I. Dambrova M, et al. Among authors: liepinsh e. Eur J Pharmacol. 2008 Mar 31;583(1):128-34. doi: 10.1016/j.ejphar.2008.01.015. Epub 2008 Jan 26. Eur J Pharmacol. 2008. PMID: 18275958

7

Effect of inhibiting carnitine biosynthesis on male rat sexual performance.

Dambrova M, Cirule H, Svalbe B, Zvejniece L, Pugovichs O, Zorenko T, Kalvinsh I, Liepinsh E, Belozertseva I. Dambrova M, et al. Among authors: liepinsh e. Physiol Behav. 2008 Oct 20;95(3):341-7. doi: 10.1016/j.physbeh.2008.06.012. Epub 2008 Jun 29. Physiol Behav. 2008. PMID: 18640137

8

Mildronate decreases carnitine availability and up-regulates glucose uptake and related gene expression in the mouse heart.

Liepinsh E, Vilskersts R, Skapare E, Svalbe B, Kuka J, Cirule H, Pugovics O, Kalvinsh I, Dambrova M. Liepinsh E, et al. Life Sci. 2008 Oct 24;83(17-18):613-9. doi: 10.1016/j.lfs.2008.08.008. Epub 2008 Sep 3. Life Sci. 2008. PMID: 18801379

9

Quantitative analysis of phenibut in rat brain tissue extracts by liquid chromatography-tandem mass spectrometry.

Grinberga S, Zvejniece L, Liepinsh E, Dambrova M, Pugovics O. Grinberga S, et al. Among authors: liepinsh e. Biomed Chromatogr. 2008 Dec;22(12):1321-4. doi: 10.1002/bmc.1059. Biomed Chromatogr. 2008. PMID: 19034959

10

Mildronate, a regulator of energy metabolism, reduces atherosclerosis in apoE/LDLR-/- mice.

Vilskersts R, Liepinsh E, Mateuszuk L, Grinberga S, Kalvinsh I, Chlopicki S, Dambrova M. Vilskersts R, et al. Among authors: liepinsh e. Pharmacology. 2009;83(5):287-93. doi: 10.1159/000210015. Epub 2009 Mar 27. Pharmacology. 2009. PMID: 19325254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page